Sato, Akinori <br/><br/>
17-Allylamino-17-demethoxygeldanamycin and ritonavir inhibit renal cancer growth by inhibiting the expression of heat shock factor-1.  [electronic resource] 

 -  International journal of oncology  Jul 2012 
 - 46-52 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1791-2423 
<br/><br/><label>Standard No.: </label>10.3892/ijo.2012.1419  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Benzoquinones--pharmacology<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Cyclin D1--metabolism<br/>Cyclin-Dependent Kinase 4--metabolism<br/>DNA-Binding Proteins--genetics<br/>Drug Synergism<br/>G1 Phase Cell Cycle Checkpoints<br/>Gene Expression--drug effects<br/>Gene Expression Profiling<br/>Gene Knockdown Techniques<br/>HSP90 Heat-Shock Proteins--antagonists & inhibitors<br/>Heat Shock Transcription Factors<br/>Humans<br/>Kidney Neoplasms--drug therapy<br/>Lactams, Macrocyclic--pharmacology<br/>RNA Interference<br/>Ritonavir--pharmacology<br/>Transcription Factors--genetics